| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |